Effects of angiotensin type 1 receptor antagonists on Parkinson's disease progression : an exploratory study in the PPMI database
Abstract: Introduction. We explored the potential clinical effects of angiotensin-II AT1 receptor blockers (ARBs) and angiotensin-converting enzyme inhibitors (ACEIs) in patients from the Parkinson’s Progress Marker Initiative (PPMI) study database. Methods. We included 423 newly diagnosed PD patie...
Guardado en:
| Autores principales: | Udovin, Lucas Daniel, Otero Losada, Matilde, Bordet, Sofía, Chevalier, Guenson, Quarracino, Cecilia, Capani, Francisco, Pérez Lloret, Santiago |
|---|---|
| Formato: | Artículo |
| Lenguaje: | Inglés |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://repositorio.uca.edu.ar/handle/123456789/11625 |
| Aporte de: |
Ejemplares similares
-
Effects of angiotensin type 1 receptor antagonists on Parkinson's disease progression : an exploratory study in the PPMI database
por: Udovin, Lucas Daniel, et al.
Publicado: (2021) -
The renin–angiotensin system modulates dopaminergic neurotransmission : A new player on the scene
por: Kobiec, Tamara, et al.
Publicado: (2021) -
On the diagnosis of pain in Parkinson disease : a mechanism-based approach
por: Mylius, Veit, et al.
Publicado: (2023) -
Neuroprotective properties of cannabinoids in cellular and animal models : hypotheses and facts
por: Udovin, Lucas Daniel, et al.
Publicado: (2021) -
Genetics of neurogenic orthostatic hypotension in Parkinson’s disease, results from a cross-sectional in silico study
por: Chevalier, Guenson, et al.
Publicado: (2023)